Who Owns Surgalign Company?

Surgalign Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns Surgalign Now?

Understanding the Surgalign SWOT Analysis is crucial, but have you ever wondered who truly controls the future of this medical technology innovator? The Surgalign company story is one of dramatic shifts and strategic pivots, making its ownership structure a complex puzzle. From its origins to its recent Chapter 11 bankruptcy, the cast of characters behind Surgalign has constantly evolved.

Before diving into the current Surgalign ownership landscape, it's essential to grasp the significant impact of the 2023 bankruptcy on the Surgalign company. This event fundamentally altered the roles of Surgalign investors, Surgalign executives, and other stakeholders, reshaping the company's trajectory. The following analysis will provide a detailed look at the Surgalign ownership structure post-bankruptcy, including the key players and their influence.

The journey of Surgalign Holdings, Inc. began in 1997 as Regeneration Technologies, Inc. The initial focus was on processing donated human and animal tissues for medical implants. Unfortunately, specific details about the founders and their initial equity distribution are not readily available in public records.

Over the years, the company underwent several transformations, including name changes and strategic acquisitions. These changes likely impacted the ownership structure, potentially diluting the stakes of the original founders and bringing in new investors. The evolution of the company from its early days to its current focus as a pure-play spine company is a testament to its adaptability.

The company's evolution is a story of strategic shifts and adaptations in the medical technology landscape. The company's early operations involved processing donated human musculoskeletal tissue and animal tissue to produce implants.

Early Days

Regeneration Technologies, Inc. was founded in 1997. The company started with a focus on processing donated tissues. The company's early work involved allograft and xenograft implants.

Name Changes

The company reincorporated in Delaware in August 2000. It went through several name changes over the years. These changes reflect the company's evolving focus and strategy.

Acquisitions and Focus

The acquisition of Pioneer Surgical Technology, Inc. in July 2013 was a significant event. By July 2020, the company became a pure-play spine company. This shift led to a name change to Surgalign Holdings, Inc.

Ownership Evolution

Early corporate restructurings and acquisitions influenced the ownership landscape. Founder stakes may have been diluted. New investors were likely brought in during these periods.

Focus on Spine

The company's strategic shift to become a pure-play spine company was crucial. This change in focus occurred after the disposition of its OEM businesses. This strategic move reshaped Surgalign's identity.

Impact on Shareholders

The evolution of Surgalign has had an impact on its shareholders. Understanding the changes in ownership is key. The company's journey highlights the dynamic nature of the medical device industry.

The evolution of Surgalign, from its inception as Regeneration Technologies, Inc. to its current form as Surgalign Holdings, Inc., illustrates a significant transformation in the medical technology sector. The company's early focus on tissue processing and the subsequent shift to a pure-play spine company reflect strategic decisions aimed at capitalizing on market opportunities. The company's history, including its name changes and acquisitions, has shaped its ownership structure over time. For more detailed information, you can read a Brief History of Surgalign.

Key Takeaways

The early ownership of Surgalign is not fully detailed in public records. The company's evolution involved name changes and acquisitions. Surgalign is now a pure-play spine company.

• The company's initial focus was on tissue processing.
• The company reincorporated in Delaware in August 2000.
• The acquisition of Pioneer Surgical Technology, Inc. occurred in July 2013.
• Surgalign became a pure-play spine company by July 2020.

Surgalign SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership of the Surgalign company underwent a significant transformation, particularly in the years leading up to its bankruptcy. Initially, the company was publicly traded on The Nasdaq Global Select Market under the ticker symbol 'SRGA'. Surgalign's financial struggles, including operational losses and cash flow issues, led to a Chapter 11 bankruptcy filing in June 2023. This filing resulted in the delisting of Surgalign's stock from Nasdaq and its subsequent move to the OTC market under the symbol 'SRGAQ'.

As part of the bankruptcy proceedings, Surgalign's assets were sold to various entities. Xtant Medical Holdings, Inc. emerged as a major stakeholder, acquiring key product lines and offerings. Augmedics, Inc. also acquired Surgalign's digital health assets. These acquisitions significantly altered the ownership landscape, with the operational components of the former Surgalign now largely held by Xtant Medical and Augmedics.

The evolution of Surgalign's ownership reflects the financial challenges faced by the company. The shift from a publicly traded entity to a fragmented ownership structure, with key assets acquired by other companies, highlights the impact of bankruptcy on the company's stakeholders. For more insights into the company's strategic direction, you can explore the Growth Strategy of Surgalign.

Key Takeaways on Surgalign Ownership

The ownership structure of Surgalign changed dramatically due to financial difficulties and bankruptcy.

• Surgalign was delisted from Nasdaq and moved to the OTC market.
• Xtant Medical and Augmedics acquired significant assets.
• The company's financial struggles led to major shifts in ownership.
• Investors and stakeholders experienced significant changes.

Surgalign PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Prior to its bankruptcy and the subsequent asset sales, the question of Surgalign ownership centered on the board of directors, which oversaw the company's strategic direction. However, following the Chapter 11 bankruptcy filing in June 2023, and the divestiture of its core businesses, the original Surgalign Holdings, Inc. essentially ceased to exist as an independent entity. This means that the previous board of directors and their associated voting power are no longer relevant in the context of an ongoing, independent company. The focus has shifted to the acquiring entities.

For example, Xtant Medical Holdings, Inc. now owns and controls the acquired hardware and biologics businesses, and its board of directors and voting structure now govern these operations. Similarly, Augmedics, Inc. controls the digital health assets it acquired from Surgalign. Information regarding the specific individuals on Surgalign's board of directors immediately prior to its bankruptcy, or any special voting rights, is not pertinent to its current, dissolved state. For further insights, consider exploring the Growth Strategy of Surgalign.

The Surgalign ownership structure has fundamentally changed due to the bankruptcy and asset sales. Surgalign investors and anyone seeking to understand the current state of the company should focus on the acquiring entities and their respective leadership teams. Details about Surgalign executives and their roles prior to the bankruptcy are no longer directly relevant to the ongoing operations of the acquired businesses. Information on Surgalign company financials and Surgalign company performance pre-bankruptcy is also of limited value in understanding the current market position.

Understanding Surgalign's Dissolution

The original Surgalign Holdings, Inc. no longer exists as a public company. The board of directors and voting power of the pre-bankruptcy entity are not relevant. Focus on the acquiring companies like Xtant Medical Holdings, Inc. and Augmedics, Inc. for current operational details.

• Bankruptcy Filing: June 2023
• Asset Sales: Core businesses sold to other entities.
• Current Status: Dissolved as an independent entity.
• Key Takeaway: Surgalign stock is no longer traded under the original structure.

Surgalign Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The most significant recent developments in the Surgalign company's ownership profile revolve around its Chapter 11 bankruptcy filing in June 2023. This event led to the liquidation of its assets, marking a stark departure from its previous status as a publicly traded company on Nasdaq. This shift fundamentally altered the landscape of who owns Surgalign, transitioning from a structure of public shareholders to the acquisition of its assets by other entities.

Prior to the bankruptcy, in February 2023, Surgalign sold its Coflex® and CoFix™ product lines to Xtant Medical Holdings, Inc. for $17 million, generating net proceeds of $14.8 million. However, these measures proved insufficient to prevent the bankruptcy filing. Following the Chapter 11 proceedings, Xtant Medical Holdings, Inc. acquired substantially all of Surgalign's domestic and international biologics and spinal fixation offerings for $5 million in cash, plus assumed liabilities, in August 2023. The digital health business, including its HOLO AI software, was sold to Augmedics, Inc. for $1.5 million in the same month.

As of late 2023 and into 2024-2025, Surgalign no longer exists as an independent operating entity. Its assets have been acquired by other companies, fundamentally altering its ownership to be integrated within Xtant Medical Holdings, Inc. and Augmedics, Inc. The trend reflects a complete dissolution through bankruptcy and asset sales, rather than a typical evolution of ownership stakes. For further insights into the competitive environment, you can explore the Competitors Landscape of Surgalign.

Surgalign Ownership Structure

The Surgalign ownership structure has been completely restructured due to bankruptcy and asset sales. Previously a public company, its assets are now held by Xtant Medical Holdings, Inc. and Augmedics, Inc.

Impact of Bankruptcy

The Chapter 11 bankruptcy filing in June 2023 was a pivotal event. It led to the liquidation of assets, marking a complete shift from its previous status as a publicly traded company on Nasdaq. This impacted Surgalign investors.

Key Acquisitions

Xtant Medical Holdings, Inc. acquired significant assets, including biologics and spinal fixation offerings. Augmedics, Inc. acquired the digital health business, including software. These acquisitions reshaped who owns Surgalign.

Financial Transactions

Notable transactions include the sale of product lines for $17 million and the acquisition of assets for $5 million plus liabilities. The digital health business was sold for $1.5 million. These transactions were part of the Surgalign company financials.

Surgalign Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs